CVS Health Q2 Adjusted EPS $2.21 Beats $2.12 Estimate, Sales $88.92B Beat $86.74B Estimate
Portfolio Pulse from Benzinga Newsdesk
CVS Health reported Q2 earnings of $2.21 per share, beating the analyst consensus estimate of $2.12 by 4.25%. However, this is a 7.92% decrease from the same period last year. The company also reported quarterly sales of $88.92 billion, beating the estimate of $86.74 billion by 2.51%, marking a 10.27% increase from last year.
August 04, 2023 | 10:49 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CVS Health's Q2 earnings and sales beat estimates, but earnings are down 7.92% YoY. Sales increased by 10.27% YoY.
CVS Health's Q2 earnings beat estimates, which is a positive signal to investors and could drive the stock price up. However, the YoY decrease in earnings might temper this positive impact. The increase in sales YoY and beating sales estimates are also positive signals that could boost the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100